Expertise in
5
conditions

Peter M. Clifton

Frome Road, 
Adelaide, SA, AU 
Expertise in
5
conditions
Frome Road, 
Adelaide, SA, AU 

Overview

Peter Clifton practices practicing medicine in Adelaide, Australia.

Mr. Clifton is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Familial Hypertriglyceridemia, Obesity, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

He is actively involved in clinical research, co-authoring 174 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Frome Road, Adelaide, SA 5000, Australia
Other Locations
North Terrace, Adelaide, SA, Australia
Room P5-16 Playford Building, Frome Rd, Adelaide, SA 5000, Australia
75 Commercial Rd, Melbourne, VIC 3004, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Mixed Dyslipidemia
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Mixed Dyslipidemia
Enrollment Status: Completed
Publish Date: April 14, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
Enrollment Status: Completed
Publish Date: March 24, 2026
Intervention Type: Drug
Study Drug: ARO-APOC3
Study Phase: Phase 2
A Phase 1 Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-APOC3 in Adult Healthy Volunteers as Well as in Severely Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome
A Phase 1 Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-APOC3 in Adult Healthy Volunteers as Well as in Severely Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome
Enrollment Status: Completed
Publish Date: December 24, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1 Single and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-ANG3 in Adult Healthy Volunteers and in Dyslipidemic Patients
A Phase 1 Single and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-ANG3 in Adult Healthy Volunteers and in Dyslipidemic Patients
Enrollment Status: Completed
Publish Date: December 24, 2025
Intervention Type: Drug
Study Drug: ARO-ANG3
Study Phase: Phase 1
View 3 Less Clinical Trials

174 Total Publications

Durability of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 with CTX310.
Durability of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 with CTX310.
Journal: The New England journal of medicine
Published: August 28, 2026

Frequently Asked Questions about Peter M. Clifton

Is Peter M. Clifton a top-rated expert for Familial Hypertriglyceridemia?

MediFind is an objective health platform that identifies experts based on real-world data. Peter M. Clifton is classified as an Distinguished expert for Familial Hypertriglyceridemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter M. Clifton participate in research or clinical trials?

Yes. Peter M. Clifton has published 174 articles and abstracts on conditions like Familial Hypertriglyceridemia. You can view a list of Peter M. Clifton's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Clifton's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile